Corpusense

Align Technology (ALGN) earnings call transcript summary & sentiment

Last call Wed 29 Jul 2026·Next Wed 28 Oct 2026

Our read on the 29 July 2026 earnings call

Overall tone: Mixed

Overall tone

Mixed

Executive Summary

Align Technology delivered total revenues of $1,056.2 million in Q2 2026 (+4.3% YoY), driven by record clear aligner volumes of 692,000 cases (+7.4% YoY) and 8.2% clear aligner revenue growth.

Core Signals

Revenue Growth & Demand: Clear aligner revenue grew 8.2% YoY to $870.9 million behind record volume of 692,000 cases, offsetting an 10.8% YoY decline in Systems and Services revenue to $185.3 million.

Bullish Signals

Record Q2 clear aligner shipments reached 692,000 cases (+7.4% YoY), powered by double-digit expansion in APAC, EMEA, and Latin America.

Risk Signals

Systems and Services Q2 revenue declined 10.8% YoY and full-year guidance was lowered to down 6% to 8% YoY due to persistent capital equipment headwinds.

Q&A Signals

Repeated analyst topics: Analysts repeatedly focused on the mechanics driving lower scanner revenue, the durability of clear aligner ASPs, and green shoots in North American retail channels.

Key Investor Debate

The primary investor debate centers on whether the severe top-line decline in Systems and Services reflects underlying market share loss and capital equipment freeze…

Analyst Takeaway

Align is successfully leveraging operational efficiencies and non-comprehensive product lines to drive strong gross margins and record clear aligner volumes despite a challenging macro backdrop.

Those are the opening lines. The full read covers the whole earnings transcript: every bullish and bearish signal, what analysts pressed hardest on, and where management answered vaguely — each with the quote behind it. Every line sourced.

See the full Earnings Highlight

Themes across Align Technology and the Health Care sector

Analyse a theme over quarters — what's brand new, what's being talked about more, and what is spreading to more companies across the sector.

Unlock themes

Ask about Align Technology's earnings, or other S&P 500 earnings calls

Ask across the corpus, instead of reading one call at a time. Scope it to Align Technology, its sector, or every name we cover — plain English, no operators — and answers come back structured: a summary, the drivers, and a read on each company.

"What did Align Technology say about margins, and did the framing change from last quarter?"

"Did Align Technology's management walk back any full-year guidance, and how did they frame it?"

"Where did Align Technology avoid answering on capital allocation?"

Unlock search

Earnings call history & sentiment

All 7 of its last calls fell on a Wednesday, every one at 16:30 ET, after the close.

Date Day Period Corpusense read
2026-07-29Wednesday2026 Q3Mixed
2026-04-29Wednesday2026 Q2Positive
2026-02-04Wednesday2026 Q1Positive
2025-10-29Wednesday2025 Q4—
2025-07-30Wednesday2025 Q3—
2025-04-30Wednesday2025 Q2—
2025-02-05Wednesday2025 Q1—

Earnings calls across Health Care Equipment & Supplies

The companies Align Technology is read alongside. Each has its own earnings call dates and sentiment.

ABTAbbott LaboratoriesBAXBaxter InternationalBDXBecton DickinsonBSXBoston ScientificCOOCooper Companies (The)DXCMDexcomEWEdwards LifesciencesGEHCGE HealthCare

Align Technology is one of the S&P 500 companies we track

Sentiment analysis on any single earnings call, themes building across a sector, and search across every company and quarter — each claim linked back to the passage it came from.

Create a free account See the full calendar Plans & pricing